Factors that might impact intrathecal drug delivery (IDD) dose escalation: A longitudinal study

Pain Practice

Volumn 14, Issue 4, 2014, Pages 301-308

  Mekhail, Nagy ^a   Mahboobi, Ramatia ^a   Farajzadeh Deroee, Armin ^a   Costandi, Shrif ^a   Dalton, Jarrod ^a   Guirguis, Maged ^a   Mehta, Pankaj ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Dose escalation predictors; Implantable; Infusion pumps; Intraspinal drug delivery; Intrathecal opioids; Neuropathic pain

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; FEMALE; FOLLOW UP; HUMAN; IMPLANTABLE PUMP; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NEUROPATHIC PAIN; OUTCOME ASSESSMENT; PAIN ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; ELECTRONIC MEDICAL RECORD; INTRASPINAL DRUG ADMINISTRATION; PAIN; PAIN MEASUREMENT; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; DRUG DELIVERY SYSTEMS; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INJECTIONS, SPINAL; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; PAIN; PAIN MEASUREMENT; RETROSPECTIVE STUDIES;

EID: 84897408358     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/papr.12096     Document Type: Article

References (25)

1. Koulousakis A, Kuchta J, Bayarassou A, Sturm V. Intrathecal opioids for intractable pain syndromes. Acta Neurochir Suppl. 2007;97(Pt 1):43-48.
2. Deer TR, Smith HS, Cousins M, et al. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician. 2010;13:E175-E213.
3. Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP. Age-dependent opioid escalation in chronic pain patients. Anesth Analg. 2005;100:1740-1745.
4. Rauck RL, Cherry D, Boyer MF, et al. Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. J Pain. 2003;4:441-447.
5. Veizi IE, Hayek SM, Narouze S, Pope JE, Mekhail N. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients. Pain Med. 2011;12:1481.
6. Baron R. Mechanisms of disease: neuropathic pain - a clinical perspective. Nat Clin Pract Neurol. 2006;2:95-106.
7. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85:S3-S14.
8. O'Connor AB. Neuropathic pain: a review of the quality of life impact, costs, and cost-effectiveness of therapy. Pharmacoeconomics. 2009;27:95-112.
9. Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2012;12:304-314.
10. Krames ES. Spinal administration of opioids and other analgesic compounds. In: Waldman SD, ed. Interventional Pain Management. 2nd ed. Philadelphia: W. B. Saunders; 2001:593-603.
11. Martell BA, O'Connor PG, Kerns RD, et al. Opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116-127.
12. Khoromi S, Cui L, Nackers L, Max MB. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain. 2007;130:65-75.
13. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352:1324-1334.
14. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104:570-587.
15. Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith H. Opioids in chronic noncancer pain. Expert Rev Neurother. 2010;10:775-789.
16. Cousins MJ, Mather LE. Intrathecal and epidural administration of opioids. Anesthesiology. 1984;61:276-310.
17. Portenoy RK. Tolerance to opioid analgesics: clinical aspects. Cancer Surv. 1994;21:49-65.
18. Bernards CM. Understanding the physiology and pharmacology of epidural and intrathecal opioids. Best Pract Res Clin Anaesthesiol. 2002;16:489-505.
19. Roberts LJ, Finch PM, Goucke CR, Price LM. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain. 2001;5:353-361.
20. Atli A, Theodore BR, Turk DC, Loeser JD. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. Pain Med. 2010;11:1010-1016.
21. Kumar K, Kelly M, Pirlot T. Continuous intrathecalmorphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol. 2001;55:79-86.
22. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study. J Pain Symptom Manage. 1996;11:71-80.
23. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Symptom Manage. 1996;11:333-352.
24. Sarvela J, Halonen P, Soikkeli A, et al. Adouble-blinded, randomized comparison of intrathecal and epidural morphine for elective cesarean delivery. Anesth Analg. 2002;95:436-440.
25. Sylvester RK, Lindsay SM, Schauer C. The conversion challenge: from intrathecal to oral morphine. Am J Hosp Palliat Care. 2004;21:143-147.